Lymphoma is the most common type of blood cancer and it is caused by abnormal growth and reproduction of white blood cells called lymphocytes. Patients are more likely to be older than age 60; men and women equally. It usually manifests first with swollen but painless lymph nodes. Prognosis can be encouraging for the more common non-Hodgkin’s lymphoma.

Where To Find Information On Lymphoma Clinical Trials

There are two main sources for information about lymphoma clinical trials, according to the Lymphoma Research Foundation, the largest non-profit organization in the country devoted exclusively to funding innovative lymphoma research and providing public information.

The website at National Institutes of Health (NIH), sponsored by the National Library of Medicine and the NIH, and includes hundreds of lymphoma trials. Another website at the National Cancer Institute (NCI) also lists lymphoma clinical trials.

Additionally, clinicaltrials.gov operated by the U.S.  government, lists all clinical trials worldwide for lymphoma and other diseases. While the lists are comprehensive, the search function and information presented has been reported to be less user-friendly than sites managed by advocacy groups.

To participate in a lymphoma clinical trial, patients must fulfill requirements regarding age, sub-type of lymphoma and stage, previous types of treatments, timing, response, and overall health condition.

Other characteristics like geographic area may also be required. Hundreds of clinical trials are currently taking place in hospitals, cancer centers and laboratories nationwide. Prior to applying or accepting participate in a study, it is important for patients to carefully read the clinical trial’s fact sheet and all information provided.

Current Notable Lymphoma Clinical Trials:

For lymphoma clinical trials currently recruiting patients, log on clinicaltrials.gov

RSS ClinicalTrials.gov: lymphoma | Recruiting Studies | Studies received in the last 14 days

  • An error has occurred, which probably means the feed is down. Try again later.

More Lymphoma Insights


Leave a Comment

Your email address will not be published. Required fields are marked *